首页> 外文期刊>Vaccine >Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media
【24h】

Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media

机译:在含血清和无血清培养基中通过波微载体培养MDCK细胞产生流感病毒

获取原文
获取原文并翻译 | 示例
       

摘要

A process for equine influenza virus vaccine production using a microcarrier system (Cytodex 1) in a 2 L Wave bioreactor is described. Growth of Madin Darby canine kidney (MDCK) cells in serum containing GMEM medium (SC) is compared to growth in serum-free Ex-Cell MDCK medium (SF) without washing steps and medium exchange before infection. Cultivations with microcarrier concentrations of 2 and 4 g/L for both media are shown. Metabolic data from carbon and amino acid metabolism are discussed. Additionally, in roller bottle experiments the influence of multiplicity of infection (moi) and trypsin concentration on the HA value was investigated. Analysis of HA and TCID(50) at 37 degrees C showed a stable HA of maximum 2.6 log HA/100 microL for 2 weeks. Peak TCID(50) titers of 10(7.7) viruses/mL were achieved 20h post infection, but infectivity was below detection limit after 150 h. Cell attachment onto microcarriers under serum-free conditions was improved by Ca(2+) addition and by cell harvesting without trypsin using only an EDTA/PBS solution. For the wave cultivation maximum virus titers of 2.3-2.6 log HA units/100 microL were reached from infection with a moi of 0.05. However, in SF medium pH dropped to less than pH 6.8 which resulted in lower HA titers of 1.7 log HA units/100 microL. For the higher microcarrier concentration (4 g/L) medium exchange steps (500 mL) were needed for both media. Omission of the washing step and medium exchange before infection in SF medium clearly simplified the influenza production process; however, for higher virus yields a better pH control of the wave bioreactor would be required. Higher cell densities (2.8 x 10(6) cells/mL for 2 g/L microcarrier) and better attachment compared to stirred tank bioreactors showed, that the wave bioreactor is a good alternative to stirred tank processes for expanding production capacities in case of a pandemic.
机译:描述了在2L Wave生物反应器中使用微载体系统(Cytodex 1)生产马流感病毒疫苗的方法。将含有GMEM培养基(SC)的血清中Madin Darby犬肾(MDCK)细胞的生长与无血清的Ex-Cell MDCK培养基(SF)的生长进行比较,无需清洗步骤,在感染前进行培养基交换。显示了两种培养基中微载体浓度分别为2和4 g / L的培养。讨论了来自碳和氨基酸代谢的代谢数据。此外,在滚瓶实验中,研究了感染复数(moi)和胰蛋白酶浓度对HA值的影响。在37摄氏度下对HA和TCID(50)的分析显示2周内最大2.6 log HA / 100 microL的稳定HA。感染后20h,TCID(50)滴度达到10(7.7)病毒/ mL的峰值,但150 h后,感染力低于检测极限。通过添加Ca(2+)和不使用胰蛋白酶仅使用EDTA / PBS溶液进行细胞收获,可以改善无血清条件下细胞对微载体的附着。对于波浪培养,感染的最大病毒滴度达到2.3-2.6 log HA单位/ 100 microL,moi为0.05。但是,在SF培养基中,pH降至pH 6.8以下,导致HA滴度较低,为1.7 log HA单位/ 100 microL。对于更高的微载体浓度(4 g / L),两种培养基都需要进行培养基交换步骤(500 mL)。在SF培养基中感染之前省略清洗步骤和更换培养基显然简化了流感的生产过程;然而,为了获得更高的病毒产量,将需要更好地控制波动生物反应器的pH。与搅拌釜式生物反应器相比,更高的细胞密度(对于2 g / L微载体而言,密度为2.8 x 10(6)个细胞/ mL)和更好的附着性表明,波动生物反应器是搅拌釜工艺的一个很好的替代方案,可以在发生水污染的情况下扩大生产能力大流行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号